An efficient enantioselective synthesis of sn-2-aminooxy (AO) analogues of lysophosphatidic acid (LPA) that possess palmitoyl and oleoyl acyl chains is presented. Both sn-2-AO LPA analogues are agonists for the LPA 1 , LPA 2 , and LPA 4 G-protein-coupled receptors, but antagonists for the LPA 3 receptor and inhibitors of autotaxin (ATX). Moreover, both analogues stimulate migration of intestinal epithelial cells in a scratch wound assay.
analogues 15 are modest agonists for LPA 3 with 10-fold lower potency than the parent oleoyl LPA. Finally, the sn-2-F LPA analogs 16 show relatively weak agonist activity for all LPA receptor isoforms.
Recently, series of novel cytotoxic phospholipids, LPA-like serine amide phosphates (SAPs) were synthesized and demonstrated to be low micromolar inhibitors of prostate tumor cell proliferation. 17 The key element of this structure was the presence of a primary amine at the sn-2 position. Rather than introduce a strongly basic group into the LPA structure, our approach was to introduce the less basic but strongly nucleophilic aminooxy (AO) group at the sn-2 position. AO compounds are frequently employed as potent inhibitors of pyridoxal-5-phosphate-dependent enzymes, such as aminotransferases, serine hydroxymethyltransferase, tyrosine decarboxylase, cystationase, and ornithine decarboxylase, whereby the aminooxy moiety forms a stable oxime with the aldehyde group present on the cofactor. [18] [19] [20] [21] [22] AO analogues have also been demonstrated to function in vitro as potent antimalarial agents. 23 We used the Mitsunobu reaction to introduce the AO functionality in stereocontrolled manner using straightforward protection and deprotection steps, thus elaborating an efficient synthetic approach to produce enantiomerically pure sn-2 AO-LPA analogues. Herein we describe the asymmetric total syntheses of two sn-2-AO LPA analogues, as well as evaluation in pharmacological, biochemical, and cell biological assays that reveal unexpected agonist and antagonist activities.
Synthesis
The synthesis of sn-2-AO LPA started with benzylation of (S)-solketal (1) (Scheme 1), followed by removal of the isopropylidene with an acidic ion-exchange resin, 24, 25 to give intermediate diol 2. Next, TBDMS was introduced 26, 27 at the primary hydroxyl group at 0-3°C to produce precursor 3, which was transformed via a Mitsunobu reaction at 0 °C 28,29 into phthalimide derivative 4 with clean inversion of configuration at the stereogenic center. Hydrazine monohydrate treatment of compound 4 29 afforded the aminooxy intermediate 5 in quantitative yield. The enantiomeric purity of the aminooxy compound was verified by conversion to the (R)-Mosher amide; 30 19 F NMR showed that intermediate 5 to have >95% enantiomeric purity. Next, the aminooxy group of 5 was reprotected with Boc to produce derivative 6, and the benzyl ether was hydrogenolyzed to yield alcohol 7 in over 95% yield. Compound 7 was converted to the palmitoyl (8a) and oleoyl (8b) esters using carbodiimide chemistry, and deprotection of the silyl ether with Bu 4 NF 26 in THF smoothly produced intermediates 9a and 9b in high yields.
In attempting to remove both methyl and Boc protecting groups, neither an excess of TMSBr nor TMSBr followed by TFA, nor anhydrous HCl gave any desired product. Finally, each ester 11a and 11b was treated with BSTFA (N,Obis(trimethylsilyl)trifluoroacetamide) 32 and TMSBr for 1 h under strict anhydrous condition in CH 2 Cl 2 , followed by addition of a wet CH 2 Cl 2 (0.5% water) with stirring for 45 min. The crude compounds were then dried in vacuo, and 10% aq. methanol was added, which resulted in simultaneous deprotection of Boc group and the phosphate methyl esters. The desired compounds 12a and 12b (Scheme 2) were obtained in homogeneous form in good yields after filtration of each methanol solution through a Whatman PTFE Syringe Filter.
Pharmacology of AO-LPA Analogues on LPA Receptors
The pharmacological properties of AO-LPA analogues 12a and 12b were evaluated on LPA [1] [2] [3] GPCRs in the McArtl rat hepatoma cell line RH7777, and on LPA 4 in CHO cells. 
Activity of AO-LPA Analogues on Cell Migration
The AO-LPA analogues 12a and 12b enhanced rate cell migration in IEC-6 human intestinal endothelial cells in a scratch wound assay (Figure 2 ). In this assay, the rate of cell migration is measured by the time it takes for the cells to close a gap in the cell monolayer created by "scratching" the monolayer with a pipet tip. This effect is congruent with the agonist activity toward the LPA 2 receptor, which is coupled to the Rho/Rac1 small GTPases and augments cell migration and cell survival. 33 The replacement of the sn-2 hydroxy group of LPA with the more nucleophilic aminooxy function afforded AO-LPA analogues 12a and 12b. This small structural change has profound effects on the receptor pharmacology and cell biology of the analogues. Instead of the pan-receptor agonist activity exhibited by LPA, 12a and 12b are weak agonists for LPA 1 and LPA 4 , strong agonists for LPA 2 , and antagonists for the LPA 3 . This mixed profile isoform selectivity makes them useful research tools for cell biology. Moreover, their ability to enhance migration of intestinal epithelial cells in vitro suggests therapeutic potential for repair of the gastrointestinal epithelium in vivo.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Structures of LPA, OMPT, HE-LPA, and SAP. Compounds 12a and 12b promote cell migration in a scratch wound assay using IEC-6 cells.
The basal rate of cell motility was measured in the presence of 0.1% BSA vehicle for stabilizing the LPA or LPA analogue, and the maximal LPA-induced response was evoked by treatment with 100 nM LPA. The bars represent the mean rate of cell migration in scratch wounds treated with different concentrations of 12a and 12b. The results represent the rate of migration over an 8 h period and the mean of 8 experiments.
Scheme 1.
Synthesis of sn-2-AO-LPA Intermediates 9a and 9b Scheme 2.
Conversion of Intermediates to sn-2-AO-LPA Analogues 12a and 12b Inhib. % = % maximal inhibition of the response to 200 nM LPA 18:1 c NE = no effect was shown at the highest concentration (30 µM) tested.
